$150 million punitive charges on a TRT lawsuit
$150 million punitive charges on a TRT lawsuit
Introduction
The very first bellwether trial for TRT lawsuits ended in a mistrial which involved a plaintiff whose allegation against AndroGel was that it caused his heart attack, thereby bringing a pause phase. But the $150 Million verdict to be paid as punitive damage by AbbVie to an Oregon man, under the claim of false marketing is big news that brings a lot of hope to the plaintiffs. Though the federal jury has not held AbbVie responsible for the alleged injury, this Chicago verdict can undoubtedly be considered as a strong signal to alert AbbVie and makes the battle turn positively towards the Plaintiffs. This verdict will now help thousands of TRT cases to move in the just and right direction. Neural IT has hands-on experience in medical reviews and can be a potential partner for law firms looking forward to litigating TRTs.
Comments
Latest News
Attorneys Seek Reconsideration of Talc MDL Daubert Ruling
Categories: General
Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…
Philips resolves DreamStation suits for $1.1B
Categories: Settlements
Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…
FDA OKs Generic OTC Naloxone Spray Approved by FDA
Categories: FDA Related
The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.
…